American Idol Star Adam Lasher, Country Singer Amanda Jo and Physicians Lend Talents to New “Needle Free” Song for Diabetes Awareness
NASHVILLE, TENN. (PRWEB) November 02, 2015
Seeking to spread a message of hope to the estimated 29 million Americans living with diabetes, an American Idol contestant and a country music star have joined forces with medical professionals to lift their voices in song and tell the world it is possible to be living “Needle Free.”
“Needle Free” features the soulful voice of American Idol Season 14 contestant Adam Lasher and the pure country stylings of Nashville’s Amanda Jo, each of whom is living very successfully with Type 1 diabetes. Two dedicated endocrinologists, experts in the care of patients with diabetes, co-wrote and produced the song.
“Needle Free” is available for download from iTunes. For every iTunes download, 10 cents will be donated to a foundation that helps people needing insulin who can't afford it.
The promise of a needle-free life is music to the ears of people who suffer from Type 1 diabetes, an autoimmune disease where the pancreas does not produce the critical hormone insulin. Since the discovery of insulin in 1921, patients with Type 1 diabetes have required daily injections of insulin and painful finger-stick blood glucose monitoring in order to survive. However, as “Needle Free” promises, change is coming with the arrival of needle-free insulin delivery, minimally invasive glucose monitoring, and the exciting possibility of new medications restoring the body’s ability to regenerate insulin-producing cells.
Co-writer credits include Dr. Mack Harrell of Florida, immediate past-president of the American Association of Clinical Endocrinologists (AACE), and endocrinologist Dr. Claresa Levetan of Pennsylvania, former member of the AACE board of directors, along with Lasher, Amanda Jo, and Nashville songwriter/producer Billy Lee. The track was recorded in Nashville by renowned country-pop producer Kim Copeland.
“We are on the cusp of amazing new science that will help the millions of Americans living with Type 1 diabetes,” said Dr. Mack Harrell, immediate past-president of the American Association of Clinical Endocrinologists (AACE). “It is my hope that ‘Needle Free’ will serve as a springboard for a national conversation about how important it is to have diabetes education and the need for continued support for diabetes research.”
“As someone who has been studying this disease for more than 30 years, I can say without a doubt that this is an exciting time for people living with diabetes,” said Dr. Claresa Levetan, whose career path was shaped by her seeing as a young child how a neighbor’s body was ravaged by the disease. “New technologies and research developments clearly show that there will be a time in the near future when insulin-dependent diabetes patients will be living ‘Needle Free’.”
“The song ‘Needle Free’ is a way to communicate hope and optimism to people who suffer from this disease,” said Dr. Levetan. “People may think they are sentenced to a lifetime of needle pricks and pain, but change is coming. It is only a matter of time.”
Interviews with the song performers, doctors and composers are available upon request.
About Needle Free
“Needle Free” is the new song spreading a message of hope to the estimated 29 million Americans living with diabetes. Performed by American Idol Season 14 contestant Adam Lasher, (http://www.adamlasherband.com/) and Nashville’s Amanda Jo (http://www.amandajocountry.com/), both of whom are living very successfully with Type 1 diabetes, it was written by Dr. Mack Harrell, immediate past-president of the American Association of Clinical Endocrinologists (AACE), and endocrinologist Dr. Claresa Levetan, former member of the AACE board of directors. For every iTunes download, 10 cents will be donated to a foundation that helps people needing insulin who can't afford it. For more information visit http://www.Facebook.com/NeedleFreeSong and follow @needlefreesong on Twitter and Instagram.
For the original version on PRWeb visit: http://www.prweb.com/releases/2015/11/prweb13056413.htm